TY - JOUR
T1 - Primary sellar melanocytoma
T2 - pathological, clinical and treatment review
AU - Albano, L.
AU - Losa, M.
AU - Barzaghi, L. R.
AU - Spatola, G.
AU - Panni, P.
AU - Terreni, M. R.
AU - Mortini, P.
N1 - Funding Information:
The authors are grateful to Taylor & Francis Group for approving the license to reproduce Figs.?1 and 2 previously published in ?Primary sellar melanocytomas: report of two cases treated at the same institution and their long-term outcome?; Albano et al. British Journal of Neurosurgery, copyright ? 2019 The Neurosurgical Foundation, reprinted by permission of Informa UK Limited.
Publisher Copyright:
© 2019, Italian Society of Endocrinology (SIE).
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/5/1
Y1 - 2020/5/1
N2 - Background: Sellar melanocytomas represent a small subgroup of primary melanocytic tumors. They arise from melanocytes located in the meningeal lining of the sellar floor or in the diaphragma sellae and this location is very uncommon. Usually, sellar melanocytomas are benign and slow-growing tumors with a high likelihood of recurrence. Purpose: To our knowledge, due to the rarity of this condition, there are no guidelines regarding their diagnosis and treatment in the medical literature to date. We have developed a narrative review, analyzing the available studies regarding primary sellar melanocytomas reported in the medical literature. We have found ten papers on this topic and all of them are case reports. In all patients, tumor diagnosis was performed after the occurrence of neurological symptoms, in particular progressive visual loss or endocrinological disorders. The diagnosis is difficult, and it requires several preoperative and postoperative investigations, but histological examination is crucial. Conclusions: Transsphenoidal surgery is the first-choice treatment. In case of tumor’s recurrence or regrowth, the role of radiation therapy and chemotherapy is not entirely clear.
AB - Background: Sellar melanocytomas represent a small subgroup of primary melanocytic tumors. They arise from melanocytes located in the meningeal lining of the sellar floor or in the diaphragma sellae and this location is very uncommon. Usually, sellar melanocytomas are benign and slow-growing tumors with a high likelihood of recurrence. Purpose: To our knowledge, due to the rarity of this condition, there are no guidelines regarding their diagnosis and treatment in the medical literature to date. We have developed a narrative review, analyzing the available studies regarding primary sellar melanocytomas reported in the medical literature. We have found ten papers on this topic and all of them are case reports. In all patients, tumor diagnosis was performed after the occurrence of neurological symptoms, in particular progressive visual loss or endocrinological disorders. The diagnosis is difficult, and it requires several preoperative and postoperative investigations, but histological examination is crucial. Conclusions: Transsphenoidal surgery is the first-choice treatment. In case of tumor’s recurrence or regrowth, the role of radiation therapy and chemotherapy is not entirely clear.
KW - Leptomeningeal melanocytes
KW - Pituitary tumor
KW - Primary melanocytic brain tumors
KW - Sellar melanocytoma
KW - Transsphenoidal surgery
UR - http://www.scopus.com/inward/record.url?scp=85076025084&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85076025084&partnerID=8YFLogxK
U2 - 10.1007/s40618-019-01158-8
DO - 10.1007/s40618-019-01158-8
M3 - Review article
C2 - 31797309
AN - SCOPUS:85076025084
VL - 43
SP - 575
EP - 585
JO - Journal of Endocrinological Investigation
JF - Journal of Endocrinological Investigation
SN - 0391-4097
IS - 5
ER -